The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model as a prognostic tool in metastatic renal cell carcinoma (mRCC) patients previously treated with first-line targeted therapy (TT)

被引：0
作者：
Ko, Jenny J.
Xie, Wanling
Heng, Daniel Yick Chin
Kroeger, Nils
Lee, Jae-Lyun
Rini, Brian I.
Knox, Jennifer J.
Bjarnason, Georg A.
Harshman, Lauren Christine
Pal, Sumanta Kumar
Yuasa, Takeshi
Smoragiewicz, Martin
Donskov, Frede
Bamias, Aristotelis
Wood, Lori
Ernst, D. Scott
Agarwal, Neeraj
Vaishampayan, Ulka N.
Rha, Sun Young
Choueiri, Toni K.
机构：
[1] Tom Baker Canc Clin, Calgary, AB, Canada
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[4] Univ Med Greifswald, Dept Urol, Greifswald, Germany
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[6] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[7] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med, Toronto, ON, Canada
[8] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[9] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[10] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[11] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan
[12] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[13] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark
[14] Alexandra Peripheral Gen Hosp, Athens, Greece
[15] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[16] London Reg Canc Ctr, London, ON N6A 4L6, Canada
[17] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[18] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[19] Yonsei Univ, Coll Med, Seoul, South Korea
[20] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.398
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398
引用
收藏
页数：1
相关论文
共 50 条
[1]   International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study [J].
Ko, Jenny J. ;
Xie, Wanling ;
Kroeger, Nils ;
Lee, Jae-Lyun ;
Rini, Brian I. ;
Knox, Jennifer J. ;
Bjarnason, Georg A. ;
Srinivas, Sandy ;
Pal, Sumanta K. ;
Yuasa, Takeshi ;
Smoragiewicz, Martin ;
Donskov, Frede ;
Kanesvaran, Ravindran ;
Wood, Lori ;
Ernst, D. Scott ;
Agarwal, Neeraj ;
Vaishampayan, Ulka N. ;
Rha, Sun-young ;
Choueiri, Toni K. ;
Heng, Daniel Y. C. .
LANCET ONCOLOGY, 2015, 16 (03) :293-300
[2]   First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). [J].
Morales, Jose Manuel Ruiz ;
Wells, J. Connor ;
Donskov, Frede ;
Bjarnason, Georg A. ;
Lee, Jae-Lyun ;
Knox, Jennifer J. ;
Beuselinck, Benoit ;
Vaishampayan, Ulka N. ;
Brugarolas, James ;
Broom, Reuben James ;
Bamias, Aristotelis ;
Yuasa, Takeshi ;
Srinivas, Sandhya ;
Ernst, D. Scott ;
Pezaro, Carmel Jo ;
Wood, Lori ;
Kollmannsberger, Christian K. ;
Rini, Brian I. ;
Choueiri, Toni K. ;
Heng, Daniel Yick Chin .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[3]   First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the international metastatic renal cell carcinoma database consortium (IMDC). [J].
Morales, Jose Manuel Ruiz ;
Swierkowski, Marcin ;
Wells, Connor ;
Fraccon, Anna Paola ;
La Russa, Francesca ;
Donskov, Frede ;
Bjarnason, Georg A. ;
Lee, Jae-Lyun ;
Sim, Hao-Wen ;
Beuselinck, Benoit ;
Wood, Lori ;
Yuasa, Takeshi ;
Pezaro, Carmel Jo ;
Rini, Brian I. ;
Szczylik, Cezary ;
Choueiri, Toni K. ;
Heng, Daniel Yick Chin .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[4]   First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). [J].
Roussel, Eduard ;
Kinget, Lisa ;
Beuselinck, Benoit ;
Albersen, Maarten ;
Wells, Connor ;
Ernst, Matthew Scott ;
Donskov, Frede ;
Schmidt, Andrew Lachlan ;
Szabados, Bernadett ;
Pal, Sumanta K. ;
Meza, Luis A. ;
Agarwal, Neeraj ;
Weickhardt, Andrew James ;
Davis, Ian D. ;
Alva, Ajjai Shivaram ;
Wood, Lori ;
Porta, Camillo ;
Choueiri, Toni K. ;
Heng, Daniel Yick Chin ;
Navani, Vishal .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[5]   Third line therapy in metastatic renal cell carcinoma (mRCC): results from the international mRCC database consortium (IMDC) [J].
Stukalina, Igor ;
Wellsa, J. Connor ;
Donskovb, Frede ;
Rinic, Brian I. ;
Leed, Jae-Lyun ;
Bjarnasone, Georg A. ;
Beuselinckf, Benoit ;
Smoragiewicz, Martin ;
Alvah, Ajjai Shivaram ;
Srinivasi, Sandy ;
Woodi, Lori ;
Saleemk, Sadia ;
Pal, Sumanta Kumar ;
Yuasam, Takeshi ;
Broomn, Reuben James ;
Kanesvaran, Ravindran ;
Bamiasp, Aristotelis ;
Knoxq, Jennifer J. ;
Henga, Daniel Y. C. ;
Choueirir, Toni K. .
BJU INTERNATIONAL, 2015, 116 :21-21
[6]   Fourth-line targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC). [J].
Stukalin, Igor ;
Wells, Connor ;
Fraccon, Anna Paola ;
Pasini, Felice ;
Porta, Camillo ;
Moreira, Raphael Brandao .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
[7]   First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An updated analysis from the International mRCC Database Consortium (IMDC). [J].
Harshman, Lauren Christine ;
Kroeger, Nils ;
Rha, Sun Young ;
Donskov, Frede ;
Wood, Lori ;
Tantravahi, Srinivas Kiran ;
Vaishampayan, Ulka N. ;
Rini, Brian I. ;
Knox, Jennifer J. ;
North, Scott A. ;
MacKenzie, Mary J. ;
Yuasa, Takeshi ;
Srinivas, Sandy ;
Pal, Sumanta Kumar ;
Heng, Daniel Yick Chin ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[8]   Third-line therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC) [J].
Heng, Daniel Yick Chin ;
Stukalin, Igor ;
Wells, Connor ;
Donskov, Frede ;
Rini, Brian I. ;
Lee, Jae-Lyun ;
Bjarnason, Georg A. ;
Beuselinck, Benoit ;
Smoragiewicz, Martin ;
Alva, Ajjai Shivaram ;
Srinivas, Sandy ;
Wood, Lori ;
Brugarolas, James ;
Pal, Sumanta Kumar ;
Yuasa, Takeshi ;
Broom, Reuben James ;
Kanesvaran, Ravindran ;
Bamias, Aristotelis ;
Knox, Jennifer J. ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[9]   Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma treated with first-line combination immunotherapies: Results from the International metastatic renal cell carcinoma database consortium (IMDC) [J].
Takemura, K. ;
Yuasa, T. ;
Lemelin, A. ;
Ferrier, E. ;
Wells, J. C. ;
Saad, E. ;
Saliby, R. M. ;
Basappa, N. S. ;
Wood, L. A. ;
Jude, E. ;
Pal, S. K. ;
Donskov, F. ;
Beuselinck, B. ;
Szabados, B. E. ;
Powles, T. B. ;
Mckay, R. R. ;
Gebrael, G. ;
Agarwal, N. ;
Choueiri, T. K. ;
Heng, D. Y. C. .
ANNALS OF ONCOLOGY, 2023, 34 :S1558-S1559
[10]   Characteristics of metastatic renal cell carcinoma (mRCC) patients treated with delayed targeted therapy: Results from the International mRCC Consortium (IMDC). [J].
Li, Haoran ;
Choueiri, Toni K. ;
Wells, Connor ;
Agarwal, Neeraj ;
Donskov, Frede ;
Lee, Jae-Lyun ;
Broom, Reuben James ;
Yuasa, Takeshi ;
Rini, Brian I. ;
Pal, Sumanta Kumar ;
Wood, Lori ;
Ernst, D. Scott ;
Kollmannsberger, Christian K. ;
Vaishampayan, Ulka N. ;
Rha, Sun Young ;
Bjarnason, Georg A. ;
Knox, Jennifer J. ;
Saleem, Sadia ;
Beuselinck, Benoit ;
Heng, Daniel Yick Chin .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345